Patent classifications
C08F20/34
CURABLE COMPOSITION
The present invention provides a curable composition capable of securing delayed curing time for carrying out a work such as laminating or tightening after carrying out irradiation with an energy ray or heating and capable of exhibiting delayed curing property after that, regardless of whether an adherend is transparent or not. The present invention is a curable composition comprising components (A) to (C): a component (A): a compound having a (meth)acryloyl group in a molecule; a component (B): saccharin; and a component (C): at least one of a photocationic catalyst as a component (C-1) and a thermal cationic catalyst as a component (C-2).
CURABLE COMPOSITION
The present invention provides a curable composition capable of securing delayed curing time for carrying out a work such as laminating or tightening after carrying out irradiation with an energy ray or heating and capable of exhibiting delayed curing property after that, regardless of whether an adherend is transparent or not. The present invention is a curable composition comprising components (A) to (C): a component (A): a compound having a (meth)acryloyl group in a molecule; a component (B): saccharin; and a component (C): at least one of a photocationic catalyst as a component (C-1) and a thermal cationic catalyst as a component (C-2).
CARBON NANOTUBE DISPERSION
This invention provides a carbon nanotube dispersion that contains carbon nanotubes, a dispersant, a solvent, and a polymer which has a partial structure represented by formula (P1) on a side chain.
##STR00001##
(In the formula, L represents —O— or —NH—, R represents an alkylene group having 1-20 carbon atoms, T represents a substituted or unsubstituted amino group, a nitrogen-containing heteroaryl group having 2-20 carbon atoms, or a nitrogen-containing aliphatic heterocyclic group having 2-20 carbon atoms, and * represents a bond.)
POLYMER GLASS TRANSITION TEMPERATURE MANIPULATION VIA Z/E HYDRAZONE PHOTOSWITCHING
In an embodiment, the present disclosure pertains to a method of changing the glass transition temperature of a polymer. In some embodiments, the polymer includes at least one hydrazone-containing compound. In general, the methods of the present disclosure include one or more of the following steps of: (1) applying light to the polymer; and (2) thereby changing the glass transition temperature of the polymer. In another embodiment, the present disclosure pertains to a polymer having a light-adjustable glass transition temperature. In some embodiments, the polymer includes at least one hydrazone-containing compound.
POLYMER GLASS TRANSITION TEMPERATURE MANIPULATION VIA Z/E HYDRAZONE PHOTOSWITCHING
In an embodiment, the present disclosure pertains to a method of changing the glass transition temperature of a polymer. In some embodiments, the polymer includes at least one hydrazone-containing compound. In general, the methods of the present disclosure include one or more of the following steps of: (1) applying light to the polymer; and (2) thereby changing the glass transition temperature of the polymer. In another embodiment, the present disclosure pertains to a polymer having a light-adjustable glass transition temperature. In some embodiments, the polymer includes at least one hydrazone-containing compound.
Optical resin material for chromatic aberration correction
An optical resin material for chromatic aberration correction is provided including at least 5% by mass of a compound (component A) represented by formula (1) or formula (3), in which R.sub.1 to R.sub.6 each independently represent a structure represented by formula (2), in which the broken line represents a binding site; n1 represents an integer of 0 to 3; n2 represents an integer of 0 or 1; n3 represents an integer of 0 to 4; R.sub.7 represents hydrogen, an acryl group, a methacryl group, a cyanoacryl group, a cyclic ether group, an allyl group, a propargyl group, a hydroxy group, an isocyanate group, chlorine, or an optionally branched alkyl group having 1 to 8 carbon atoms; and X represents an alkylene glycol chain having 2 to 7 carbon atoms or a lactone-modified ketone chain, in which R.sub.1 to R.sub.6 each independently represent a structure represented by formula (2).
Stimuli responsive polymers for lost circulation applications
Provided is a method for mitigating a lost circulation zone. The method may include providing a lost circulation treatment composition that may include an acid responsive polymer that may include at least one monomer, at least one comonomer, and at least one crosslinker; a carbonate-based solvent; and a carrier fluid that may include water. The method may also include introducing the lost circulation treatment composition into a wellbore within a subterranean formation, wherein the subterranean formation may include the lost circulation zone; placing the lost circulation treatment composition into the lost circulation zone, hydrolyzing the carbonate-based solvent to generate carbon dioxide, and causing the swelling (change of shape) of acid responsive polymer to mitigate the losses.
Stimuli responsive polymers for lost circulation applications
Provided is a method for mitigating a lost circulation zone. The method may include providing a lost circulation treatment composition that may include an acid responsive polymer that may include at least one monomer, at least one comonomer, and at least one crosslinker; a carbonate-based solvent; and a carrier fluid that may include water. The method may also include introducing the lost circulation treatment composition into a wellbore within a subterranean formation, wherein the subterranean formation may include the lost circulation zone; placing the lost circulation treatment composition into the lost circulation zone, hydrolyzing the carbonate-based solvent to generate carbon dioxide, and causing the swelling (change of shape) of acid responsive polymer to mitigate the losses.
2-DIMETHYLAMINOETHYL ACRYLATE POLYMERS AND THEIR PREPARATION METHOD
The present invention relates to a water-soluble polymer obtained by polymerization of at least a 2-dimethylaminoethyl acrylate monomer and/or its salts, in presence of at least a tocopherol and/or its derivatives, or a tocotrienol and/or its derivatives, and its uses.
CALIXARENE COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT
Provided is a calixarene compound represented by structural formula (1). In structural formula (1), R.sup.1 and R.sup.2 each independently represent a structural moiety (A) having a functional group (I), a structural moiety (B) having a functional group (II) having a carbon-carbon unsaturated bond (excluding maleate groups), a structural moiety (C) having both the functional group (I) and the functional group (II), a monovalent organic group (D) that has 1 to 20 carbon atoms and is other than the structural moieties (A), (B) and (C), or a hydrogen atom (E). At least one of a plurality of R.sup.2s is the structural moiety (A), the structural moiety (B), the structural moiety (C), or the organic group (D).
##STR00001##